Syrian Arab Republic vs Türkiye: Treatment success rate for patients treated for MDR-TB
Syrian Arab Republic
50.0%
in 2022
Türkiye
54.0%
in 2022
Syrian Arab Republic rank
139th
Türkiye rank
136th
Treatment success rate for patients treated for MDR-TB over time
- Syrian Arab Republic
- Türkiye
How they compare
Türkiye currently reports 54.0% against 50.0% in Syrian Arab Republic, a difference of 4.0%.
That makes Türkiye's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 9 times across 17 shared years of data; in 2006 it was Syrian Arab Republic ahead.
Syrian Arab Republic ranks 139th and Türkiye ranks 136th of 163 countries.
Across the 3 decades both report, Syrian Arab Republic averaged higher in 1 and Türkiye in 2.
Head to head by decade
| Decade | Syrian Arab Republic | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.0% | 67.5% | 4.5% | Türkiye |
| 2010s | 58.2% | 62.7% | 4.5% | Türkiye |
| 2020s | 62.7% | 50.7% | 12.0% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Syrian Arab Republic or Türkiye?
- Türkiye, at 54.0% against 50.0% in Syrian Arab Republic as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Syrian Arab Republic and Türkiye?
- 4.0%, with Türkiye ahead.
- How many years of comparable data are there for Syrian Arab Republic and Türkiye?
- 17 years are reported by both, from 2006 to 2022.
- How do Syrian Arab Republic and Türkiye rank globally for treatment success rate for patients treated for mdr-tb?
- Syrian Arab Republic ranks 139th and Türkiye ranks 136th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.